Loading...
Market
Additional legal action against McKinsey related to opioids by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Legal filings and announcements from the U.S. Department of Justice or other relevant authorities
Story
FBI Boston: McKinsey to Pay $650 Million to Settle U.S. Opioid Probe Linked to Purdue Pharma on December 13, 2024
Dec 13, 2024, 02:18 PM
McKinsey & Company has agreed to pay $650 million to settle a U.S. Department of Justice investigation into its advisory role in promoting opioid sales, specifically for Purdue Pharma, the manufacturer of OxyContin. This settlement resolves both criminal and civil investigations into the consulting firm's actions, which have been linked to the opioid epidemic in the United States. The announcement was made during a news conference held by the FBI in Boston, where details about the resolution of these investigations were shared. Additionally, an ex-partner of McKinsey is expected to plead guilty to obstruction as part of the settlement.
View original story
Similar markets
Federal Trade Commission • 25%
Securities and Exchange Commission • 25%
Other • 25%
U.S. Department of Justice • 25%
No • 50%
Yes • 50%
Other • 25%
Bain & Company • 25%
McKinsey & Company • 25%
Boston Consulting Group • 25%
Less than $1 billion • 25%
$1.5 billion to $2 billion • 25%
More than $2 billion • 25%
$1 billion to $1.5 billion • 25%
Teva Pharmaceuticals • 25%
Johnson & Johnson • 25%
Other • 25%
Endo International • 25%
No significant actions • 25%
Rebrand or restructure • 25%
Reach new settlements with other firms • 25%
File for bankruptcy again • 25%
No impact on business operations • 25%
Minor impact on business operations • 25%
Significant decline in business operations • 25%
Improvement in business operations • 25%